Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5791 to 5805 of 7707 results

  1. Intra-arterial therapies to manage delayed cerebral ischaemia: What is the impact of intra-arterial therapies to manage delayed cerebral ischaemia on outcome in people with aneurysmal subarachnoid haemorrhage?

    Recommendation ID NG228/10 Question Intra-arterial therapies to manage delayed cerebral ischaemia: What is the impact of intra-arterial

  2. Impact of neonatal infection on the baby's family: What is the impact of neonatal infection on the health-related quality of life of the baby's family?

    Recommendation ID NG195/7 Question Impact of neonatal infection on the baby's family: What is the impact of neonatal infection on the health-related

  3. What is the impact of pharmacological interventions for the management of postpartum haemorrhage on breastfeeding and women's and their birth companions' experience and satisfaction in the postnatal period?

    Recommendation ID NG235/4 Question What is the impact of pharmacological interventions for the management of postpartum haemorrhage on

  4. Intracranial hypertension: What is the impact of routine monitoring of intracranial hypertension on subsequent management and outcome in people with aneurysmal subarachnoid haemorrhage who are unconscious or ventilated on an intensive care unit?

    Recommendation ID NG228/09 Question Intracranial hypertension: What is the impact of routine monitoring of intracranial hypertension on

  5. What is the impact of using the VivaScope 1500 and 3000 imaging systems in the clinical workflow of melanoma and basal cell carcinoma assessment in secondary care in England, particularly on excision rates, diagnostic accuracy, health related quality of life and associated NHS costs?

    Recommendation ID DG19/1 Question What is the impact of using the VivaScope 1500 and 3000 imaging systems in the clinical workflow of melanoma

  6. What is the improvement in the cost-effectiveness metrics for statin therapy in reducing CVD that can be obtained when using a complete individual patient-based outcomes meta-analysis data set compared with using published outcomes data?

    Recommendation ID CG181/2 Question What is the improvement in the cost-effectiveness metrics for statin therapy in reducing CVD that can

  7. What is the incidence and prevalence of, and what are the demographic trends in, skin cancer in the UK? (Demographic variables might include whether someone is an outdoor or indoor worker, their skin type and socioeconomic status.)

    Recommendation ID PH32/1 Question What is the incidence and prevalence of, and what are the demographic trends in, skin cancer in the UK

  8. Antibiotics for suspected early-onset infection: What is the incidence and severity of adverse effects with antibiotics used to prevent or treat early-onset neonatal infection?

    Recommendation ID NG195/13 Question Antibiotics for suspected early-onset infection: What is the incidence and severity of adverse effects

  9. Antibiotics for suspected early-onset infection: What is the incidence in England and Wales of resistance to commonly used antibiotics among bacteria that cause early-onset neonatal infection?

    Recommendation ID NG195/11 Question Antibiotics for suspected early-onset infection: What is the incidence in England and Wales of resistance

  10. What is the incidence of lentigo maligna diagnosed in England and which different therapies are used to treat lentigo maligna?

    Recommendation ID DG19/5 Question What is the incidence of lentigo maligna diagnosed in England and which different therapies are used

  11. Long-term effectiveness of total hip replacement: What is the long-term clinical and cost effectiveness for adults (including different subgroups) undergoing total hip replacement compared with hemiarthroplasty for displaced intracapsular hip fracture?

    Recommendation ID CG124/06 Question Long-term effectiveness of total hip replacement: What is the long-term clinical and cost effectiveness

  12. Prophylactic antibiotics for preventing exacerbations: - What is the long-term clinical and cost effectiveness of prophylactic antibiotics for people with stable COPD who are at high risk of exacerbations?

    Recommendation ID NG115/7 Question Prophylactic antibiotics for preventing exacerbations: - What is the long-term clinical and cost effectiveness

  13. Long-term effectiveness of selective laser trabeculoplasty: What is the long-term effectiveness and cost effectiveness of selective laser trabeculoplasty as a first-line treatment compared with intraocular pressure-lowering eye drops in ocular hypertension or COAG in adults?

    Recommendation ID NG81/2 Question Long-term effectiveness of selective laser trabeculoplasty: What is the long-term effectiveness and cost

  14. Individual-level interventions: What is the long-term effectiveness and cost effectiveness of universal individual-level interventions on mental wellbeing in different types of organisations?

    Recommendation ID NG212/01 Question Individual-level interventions: What is the long-term effectiveness and cost effectiveness of universal